PETMED EXPRESS, INC. Revenues
PETMED EXPRESS, INC. (PETS) reported Revenues of $74.29 million for the 3-month period ending 2020-03-31, per its 10-K filed 2020-05-26.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2020-05-26
- PETMED EXPRESS, INC. revenues for the quarter ending 2020-03-31 was $74.29M, a 15.06% increase year-over-year.
- PETMED EXPRESS, INC. revenues for the quarter ending 2019-12-31 was $59.91M, a 0.25% decline year-over-year.
- PETMED EXPRESS, INC. revenues for the quarter ending 2019-09-30 was $69.94M, a 2.04% decline year-over-year.
- PETMED EXPRESS, INC. revenues for the quarter ending 2019-06-30 was $79.99M, a 8.47% decline year-over-year.
- PETMED EXPRESS, INC. revenues for fiscal 2018 was $273.80M, a 9.88% increase from fiscal 2017.
- PETMED EXPRESS, INC. revenues for fiscal 2017 was $249.18M, a 6.18% increase from fiscal 2016.
- PETMED EXPRESS, INC. revenues for fiscal 2016 was $234.68M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-03-31 | $74.29M 10-K · filed 2020-05-26 | $134.20M derived: sum of 2 quarters · filed 2020-05-26 | $204.14M derived: sum of 3 quarters · filed 2020-05-26 | $284.13M derived: sum of 4 quarters · filed 2020-05-26 |
| 2019-12-31 | $59.91M 10-K · filed 2020-05-26 | $129.85M derived: sum of 2 quarters · filed 2020-05-26 | $209.84M derived: sum of 3 quarters · filed 2020-05-26 | $274.40M derived: sum of 4 quarters · filed 2020-05-26 |
| 2019-09-30 | $69.94M 10-K · filed 2020-05-26 | $149.92M derived: sum of 2 quarters · filed 2020-05-26 | $214.49M derived: sum of 3 quarters · filed 2020-05-26 | $274.56M derived: sum of 4 quarters · filed 2020-05-26 |
| 2019-06-30 | $79.99M 10-K · filed 2020-05-26 | $144.55M derived: sum of 2 quarters · filed 2020-05-26 | $204.62M derived: sum of 3 quarters · filed 2020-05-26 | $276.02M derived: sum of 4 quarters · filed 2020-05-26 |
| 2019-03-31 | $64.56M 10-K · filed 2020-05-26 | $124.63M derived: sum of 2 quarters · filed 2020-05-26 | $196.03M derived: sum of 3 quarters · filed 2020-05-26 | $283.42M derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-12-31 | $60.07M 10-K · filed 2020-05-26 | $131.46M derived: sum of 2 quarters · filed 2020-05-26 | $218.85M derived: sum of 3 quarters · filed 2020-05-26 | $286.18M derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-09-30 | $71.40M 10-K · filed 2020-05-26 | $158.79M derived: sum of 2 quarters · filed 2020-05-26 | $226.11M derived: sum of 3 quarters · filed 2020-05-26 | $286.22M derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-06-30 | $87.39M 10-K · filed 2020-05-26 | $154.71M derived: sum of 2 quarters · filed 2020-05-26 | $214.82M derived: sum of 3 quarters · filed 2020-05-26 | $281.53M derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-03-31 | $67.32M 10-K · filed 2019-05-28 | $127.43M derived: sum of 2 quarters · filed 2019-05-28 | $194.14M derived: sum of 3 quarters · filed 2019-05-28 | $273.80M 10-K · filed 2018-05-29 |
| 2017-12-31 | $60.11M 10-K · filed 2019-05-28 | $126.82M derived: sum of 2 quarters · filed 2019-05-28 | $206.48M derived: sum of 3 quarters · filed 2019-05-28 | $269.51M derived: sum of 4 quarters · filed 2019-05-28 |
| 2017-09-30 | $66.71M 10-K · filed 2019-05-28 | $146.37M derived: sum of 2 quarters · filed 2019-05-28 | $209.40M derived: sum of 3 quarters · filed 2019-05-28 | $262.27M derived: sum of 4 quarters · filed 2019-05-28 |
| 2017-06-30 | $79.66M 10-K · filed 2019-05-28 | $142.69M derived: sum of 2 quarters · filed 2019-05-28 | $195.56M derived: sum of 3 quarters · filed 2019-05-28 | $256.35M derived: sum of 4 quarters · filed 2019-05-28 |
| 2017-03-31 | $63.03M 10-K · filed 2018-05-29 | $115.90M derived: sum of 2 quarters · filed 2018-05-29 | $176.69M derived: sum of 3 quarters · filed 2018-05-29 | $249.18M 10-K · filed 2018-05-29 |
| 2016-12-31 | $52.87M 10-K · filed 2018-05-29 | $113.66M derived: sum of 2 quarters · filed 2018-05-29 | $186.14M derived: sum of 3 quarters · filed 2018-05-29 | |
| 2016-09-30 | $60.79M 10-K · filed 2018-05-29 | $133.28M derived: sum of 2 quarters · filed 2018-05-29 | ||
| 2016-06-30 | $72.49M 10-K · filed 2018-05-29 | |||
| 2016-03-31 | $234.68M 10-K · filed 2018-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |